[Restriction of functional disorders by the use of a regulatory peptide dalargin in burned rats infected with Staphylococcus aureus].
Pashutin
S B
SB
D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002056:Burns / Q000188:drug therapy* / Q000503:physiopathology; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013565:Sympatholytics / Q000494:pharmacology / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D013565:Sympatholytics; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Ogranichenie funktsional'nykh rasstroĭstv s pomoshch'iu reguliatornogo peptida--dalargina u obozhzhennykh krys, infitsirovannykh zolotistym stafilokokkom.